These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
447 related items for PubMed ID: 12366423
1. A comparison of psoralen plus ultraviolet A (PUVA) monotherapy, tacalcitol plus PUVA and tazarotene plus PUVA in patients with chronic plaque-type psoriasis. Tzaneva S, Hönigsmann H, Tanew A, Seeber A. Br J Dermatol; 2002 Oct; 147(4):748-53. PubMed ID: 12366423 [Abstract] [Full Text] [Related]
2. Non-invasive evaluation of tacalcitol plus puva versus tacalcitol plus UVB-NB in the treatment of psoriasis: "right-left intra-individual pre/post comparison design". Brazzelli V, Barbagallo T, Prestinari F, Rona C, De Silvestri A, Trevisan V, Borroni G. Int J Immunopathol Pharmacol; 2005 Oct; 18(4):755-60. PubMed ID: 16388725 [Abstract] [Full Text] [Related]
3. A comparison of tazarotene 0.1% gel once daily plus mometasone furoate 0.1% cream once daily versus calcipotriene 0.005% ointment twice daily in the treatment of plaque psoriasis. Guenther LC, Poulin YP, Pariser DM. Clin Ther; 2000 Oct; 22(10):1225-38. PubMed ID: 11110233 [Abstract] [Full Text] [Related]
4. Narrowband UVB and cream psoralen-UVA combination therapy for plaque-type psoriasis. Grundmann-Kollmann M, Ludwig R, Zollner TM, Ochsendorf F, Thaci D, Boehncke WH, Krutmann J, Kaufmann R, Podda M. J Am Acad Dermatol; 2004 May; 50(5):734-9. PubMed ID: 15097957 [Abstract] [Full Text] [Related]
5. Tacalcitol: A useful adjunct to narrow band ultraviolet B phototherapy in psoriasis. Aggarwal P, Aggarwal K, Jain VK. J Dermatolog Treat; 2016 Nov; 27(6):546-551. PubMed ID: 27052200 [Abstract] [Full Text] [Related]
6. Tacalcitol in the treatment of psoriasis vulgaris: the Spanish experience. Lecha M, Mirada A, López S, Artés M, T.O.P. Research Group. J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):414-7. PubMed ID: 15987284 [Abstract] [Full Text] [Related]
7. Vitamin D and psoralen plus UVA radiation. Mascaró JM. Cutis; 2002 Nov; 70(5 Suppl):13-5. PubMed ID: 12467334 [Abstract] [Full Text] [Related]
8. Long-term efficacy and safety of tacalcitol ointment in patients with chronic plaque psoriasis. van de Kerkhof PC, Berth-Jones J, Griffiths CE, Harrison PV, Hönigsmann H, Marks R, Roelandts R, Schöpf E, Trompke C. Br J Dermatol; 2002 Mar; 146(3):414-22. PubMed ID: 11952541 [Abstract] [Full Text] [Related]
9. Interactions between tazarotene and ultraviolet light. Hecker D, Worsley J, Yueh G, Kuroda K, Lebwohl M. J Am Acad Dermatol; 1999 Dec; 41(6):927-30. PubMed ID: 10570375 [Abstract] [Full Text] [Related]
10. Comparative evaluation of efficacy and safety of calcipotriol versus tacalcitol ointment, both in combination with NBUVB phototherapy in the treatment of stable plaque psoriasis. Dua I, Aggarwal K, Jain VK. Photodermatol Photoimmunol Photomed; 2017 Sep; 33(5):275-281. PubMed ID: 28602032 [Abstract] [Full Text] [Related]
11. Receptor-selective retinoids for psoriasis: focus on tazarotene. Weindl G, Roeder A, Schäfer-Korting M, Schaller M, Korting HC. Am J Clin Dermatol; 2006 Sep; 7(2):85-97. PubMed ID: 16605289 [Abstract] [Full Text] [Related]
12. Tacalcitol ointment for long-term control of chronic plaque psoriasis in dermatological practice. Lambert J, Trompke C. Dermatology; 2002 Sep; 204(4):321-4. PubMed ID: 12077538 [Abstract] [Full Text] [Related]
13. Randomized, double-blind comparison of 1 mg/L versus 5 mg/L methoxsalen bath-PUVA therapy for chronic plaque-type psoriasis. Vongthongsri R, Konschitzky R, Seeber A, Treitl C, Hönigsmann H, Tanew A. J Am Acad Dermatol; 2006 Oct; 55(4):627-31. PubMed ID: 17010742 [Abstract] [Full Text] [Related]
14. [Narrow-band UVB therapy in psoriasis vulgaris: good practice guideline and recommendations of the French Society of Photodermatology]. Beani JC, Jeanmougin M. Ann Dermatol Venereol; 2010 Jan; 137(1):21-31. PubMed ID: 20110064 [Abstract] [Full Text] [Related]
15. The effectiveness of PUVA treatment in severe psoriasis is significantly increased by additional UV 308-nm excimer laser sessions. Trott J, Gerber W, Hammes S, Ockenfels HM. Eur J Dermatol; 2008 Jan; 18(1):55-60. PubMed ID: 18086590 [Abstract] [Full Text] [Related]
16. A randomized controlled trial of narrowband ultraviolet B vs bath-psoralen plus ultraviolet A photochemotherapy for psoriasis. Dawe RS, Cameron H, Yule S, Man I, Wainwright NJ, Ibbotson SH, Ferguson J. Br J Dermatol; 2003 Jun; 148(6):1194-204. PubMed ID: 12828749 [Abstract] [Full Text] [Related]
17. Calcipotriol vs. tazarotene as combination therapy with narrowband ultraviolet B (311 nm): efficacy in patients with severe psoriasis. Schiener R, Behrens-Williams SC, Pillekamp H, Kaskel P, Peter RU, Kerscher M. Br J Dermatol; 2000 Dec; 143(6):1275-8. PubMed ID: 11122033 [Abstract] [Full Text] [Related]
18. Once-daily tazarotene gel versus twice-daily fluocinonide cream in the treatment of plaque psoriasis. Lebwohl M, Ast E, Callen JP, Cullen SI, Hong SR, Kulp-Shorten CL, Lowe NJ, Phillips TJ, Rosen T, Wolf DI, Quell JM, Sefton J, Lue JC, Gibson JR, Chandraratna RA. J Am Acad Dermatol; 1998 May; 38(5 Pt 1):705-11. PubMed ID: 9591815 [Abstract] [Full Text] [Related]
19. Comparison of Psoralen ultraviolet A (PUVA) photochemotherapy plus topical corticosteroids with PUVA plus bland emollients in the treatment of psoriasis. Tahir R, Mujtaba G. J Ayub Med Coll Abbottabad; 2005 May; 17(1):34-6. PubMed ID: 15929524 [Abstract] [Full Text] [Related]
20. A clinical evaluation of tazarotene 0.1% gel, with and without a high- or mid-high-potency corticosteroid, in patients with stable plaque psoriasis. Green L, Sadoff W. J Cutan Med Surg; 2002 May; 6(2):95-102. PubMed ID: 11992180 [Abstract] [Full Text] [Related] Page: [Next] [New Search]